{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:20:29Z","timestamp":1777526429280,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LYY19H280006"],"award-info":[{"award-number":["LYY19H280006"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503129"],"award-info":[{"award-number":["81503129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Projects of Zhejiang Medical Association","award":["2019ZYC-A85"],"award-info":[{"award-number":["2019ZYC-A85"]}]},{"name":"Medicine and Health General Research Program of Zhejiang Province","award":["2011KYA090"],"award-info":[{"award-number":["2011KYA090"]}]},{"name":"Scientific Research Projects of Hospital Pharmacy of Zhejiang Pharmaceutical Association","award":["2017ZYY07"],"award-info":[{"award-number":["2017ZYY07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10238-020-00643-2","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T09:03:43Z","timestamp":1594371823000},"page":"609-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication"],"prefix":"10.1007","volume":"20","author":[{"given":"Lian-Di","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Mei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-0156","authenticated-orcid":false,"given":"Liu-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"1","key":"643_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10238-017-0458-1","volume":"18","author":"T Tahara","year":"2018","unstructured":"Tahara T, Tahara S, Tuskamoto T, et al. Telomere length in the gastric mucosa after Helicobacter pylori eradication and its potential role in the gastric carcinogenesis. Clin Exp Med. 2018;18(1):21\u20136. https:\/\/doi.org\/10.1007\/s10238-017-0458-1.","journal-title":"Clin Exp Med."},{"issue":"Suppl 1","key":"643_CR2","doi-asserted-by":"publisher","first-page":"e12514","DOI":"10.1111\/hel.12514","volume":"23","author":"O Sjomina","year":"2018","unstructured":"Sjomina O, Pavlova J, Niv Y, et al. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23(Suppl 1):e12514. https:\/\/doi.org\/10.1111\/hel.12514.","journal-title":"Helicobacter"},{"issue":"2","key":"643_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022.","journal-title":"Gastroenterology"},{"issue":"6 Pt B","key":"643_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.semcancer.2013.07.004","volume":"23","author":"A Shiotani","year":"2013","unstructured":"Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013;23(6 Pt B):492\u2013501. https:\/\/doi.org\/10.1016\/j.semcancer.2013.07.004.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"643_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ajg.2012.132","volume":"107","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Calvet X, Cosme A, et al. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol. 2012;107(8):1197\u2013204. https:\/\/doi.org\/10.1038\/ajg.2012.132.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"643_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61(4):507\u201313. https:\/\/doi.org\/10.1136\/gutjnl-2011-300495.","journal-title":"Gut"},{"issue":"2","key":"643_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.24875\/gmm.m20000358","volume":"156","author":"S Giono-Cerezo","year":"2020","unstructured":"Giono-Cerezo S, Santos-Preciado JI, Morf\u00edn-Otero MDR, et al. Antimicrobial resistance Its importance and efforts to control it. Gac Med Mex. 2020;156(2):171\u20138. https:\/\/doi.org\/10.24875\/gmm.m20000358.","journal-title":"Gac Med Mex"},{"issue":"7","key":"643_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3760\/cma.j.issn.0578-1426.2017.07.014","volume":"56","author":"G Liu","year":"2017","unstructured":"Chinese Society of Gastroenterology; Chinese Study Group on Helicobacter pylori and Peptic Ulcer, Liu G, et al. Fifth Chinese national consensus report on the management of Helicobacter pylori infection. Zhonghua Nei Ke Za Zhi. 2017;56(7):532\u201345. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2017.07.014.","journal-title":"Zhonghua Nei Ke Za Zhi."},{"issue":"4","key":"643_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12664-019-00949-4","volume":"38","author":"SK Jha","year":"2019","unstructured":"Jha SK, Mishra MK, Saharawat K, et al. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: a prospective open-label randomized controlled trial. Indian J Gastroenterol. 2019;38(4):325\u201331. https:\/\/doi.org\/10.1007\/s12664-019-00949-4.","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"643_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/hel.12242","volume":"21","author":"L Zhou","year":"2016","unstructured":"Zhou L, Zhang J, Song Z, et al. Tailored versus triple plus bismuth or concomitant therapy as initial Helicobacter pylori treatment: a randomized trial. Helicobacter. 2016;21(2):91\u20139. https:\/\/doi.org\/10.1111\/hel.12242.","journal-title":"Helicobacter"},{"issue":"11","key":"643_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","volume":"64","author":"W Zhang","year":"2015","unstructured":"Zhang W, Chen Q, Liang X, et al. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015;64(11):1715\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2015-309900.","journal-title":"Gut"},{"issue":"1","key":"643_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12178","volume":"20","author":"C Xie","year":"2015","unstructured":"Xie C, Lu NH. Review: clinical management of Helicobacter pylori infection in China. Helicobacter. 2015;20(1):1\u201310. https:\/\/doi.org\/10.1111\/hel.12178.","journal-title":"Helicobacter"},{"issue":"5","key":"643_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","volume":"65","author":"MP Dore","year":"2016","unstructured":"Dore MP, Lu H, Graham DY. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016;65(5):870\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2015-311019.","journal-title":"Gut"},{"issue":"1","key":"643_CR14","first-page":"7","volume":"23","author":"S Kadkhodaei","year":"2020","unstructured":"Kadkhodaei S, Siavoshi F, Foroumadi A, et al. Proton pump inhibitor-treated H. pylori adjust cell envelope fatty acid and cholesterol content to survive. Arch Iran Med. 2020;23(1):7\u201314.","journal-title":"Arch Iran Med"},{"issue":"10","key":"643_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.17235\/reed.2019.6155\/2019","volume":"111","author":"J Ying","year":"2019","unstructured":"Ying J, Li LC, Wu CY, et al. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Rev Esp Enferm Dig. 2019;111(10):738\u201343. https:\/\/doi.org\/10.17235\/reed.2019.6155\/2019.","journal-title":"Rev Esp Enferm Dig"},{"issue":"43","key":"643_CR16","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.3748\/wjg.v20.i43.16029","volume":"20","author":"CH Kuo","year":"2014","unstructured":"Kuo CH, Lu CY, Shih HY, et al. CYP2C19 polymorphism infuences Helicobacter pylori eradication. World J Gastroenterol. 2014;20(43):16029\u201336. https:\/\/doi.org\/10.3748\/wjg.v20.i43.16029.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"643_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10238-018-0510-9","volume":"18","author":"L Chen","year":"2018","unstructured":"Chen L, He J, Wang L, et al. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial. Clin Exp Med. 2018;18(4):569\u201376. https:\/\/doi.org\/10.1007\/s10238-018-0510-9.","journal-title":"Clin Exp Med"},{"issue":"1","key":"643_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dky401","volume":"74","author":"MR Ram","year":"2019","unstructured":"Ram MR, Teh X, Rajakumar T, et al. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy. J Antimicrob Chemother. 2019;74(1):11\u20136. https:\/\/doi.org\/10.1093\/jac\/dky401.","journal-title":"J Antimicrob Chemother"},{"key":"643_CR19","doi-asserted-by":"publisher","first-page":"109478","DOI":"10.1016\/j.biopha.2019.109478","volume":"120","author":"ZN Lu","year":"2019","unstructured":"Lu ZN, Shi ZY, Dang YF, et al. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo. Biomed Pharmacother. 2019;120:109478. https:\/\/doi.org\/10.1016\/j.biopha.2019.109478.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"643_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/cncr.32690","volume":"126","author":"DL Hershman","year":"2020","unstructured":"Hershman DL, Accordino MK, Shen S, et al. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events. Cancer. 2020;126(7):1541\u20139. https:\/\/doi.org\/10.1002\/cncr.32690.","journal-title":"Cancer"},{"issue":"1","key":"643_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4081\/mrm.2020.654","volume":"15","author":"I Aredano","year":"2020","unstructured":"Aredano I, de Blasio F, Berchialla P, et al. Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease. Multidiscip Respir Med. 2020;15(1):654. https:\/\/doi.org\/10.4081\/mrm.2020.654.","journal-title":"Multidiscip Respir Med"},{"issue":"9","key":"643_CR22","doi-asserted-by":"publisher","first-page":"e00432-18","DOI":"10.1128\/AAC.00432-18","volume":"62","author":"Y Xie","year":"2018","unstructured":"Xie Y, Zhu Z, Wang J, et al. Ten-day quadruple therapy comprising low-dose rabeprazole, bismuth, amoxicillin, and tetracycline is an effective and safe first-line treatment for Helicobacter pylori infection in a population with high antibiotic resistance: a prospective, multicenter, randomized, parallel-controlled clinical trial in China. Antimicrob Agents Chemother. 2018;62(9):e00432-18. https:\/\/doi.org\/10.1128\/AAC.00432-18.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-020-00643-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:38:21Z","timestamp":1625877501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-020-00643-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s10238-020-00643-2","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}